PLAINSBORO, N.J., Aug. 28, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has extended the expiration date and modified the terms of its offer to exchange up to $120 million principal amount of new notes with a “net share settlement” mechanism for its currently outstanding 2 1/2% Contingent Convertible Subordinated Notes due 2008.
